GlassScriptPhysician profile
David L Weatherly
NPI 1558672998
$4,759.90
in general payments reported to CMS, 2019-2025
48 companies · $779 in 2025
The $779 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $588 · 2020: $402 · 2021: $626 · 2022: $735 · 2023: $757 · 2024: $873 · 2025: $779.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,409.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,409.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $428.20 | 2020-2024 | Bulkamid |
| Sumitomo Pharma America, INC. | $375.56 | 2023-2025 | Orgovyx |
| Dendreon Pharmaceuticals LLC | $333.69 | 2019-2025 | Provenge |
| Coloplast Corp | $232.89 | 2019-2025 | Speedicath |
| Myovant Sciences INC. | $216.17 | 2021-2022 | |
| Myriad Genetic Laboratories, INC. | $216.03 | 2021-2025 | Prolaris |
| Endo Pharmaceuticals INC. | $207.19 | 2019-2023 | Xiaflex, Edex, Aveed |
| Davol INC. | $176.96 | 2025 | Arista |
| Amgen INC. | $169.08 | 2019-2023 | Prolia |
| Smith+Nephew, INC. | $149.34 | 2019-2020 | |
| Janssen Biotech, INC. | $145.61 | 2019-2025 | Erleada, Akeega, Balversa |
| Urogen Pharma, INC. | $133.52 | 2023-2025 | Jelmyto |
| Blue Earth Diagnostics | $132.90 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $127.35 | 2019-2025 | |
| Neotract INC. | $122.32 | 2020 |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Accord Healthcare, INC. | $116.91 | 2022-2024 | |
| Calyxo, INC. | $109.39 | 2025 | Cvac Aspiration System |
| Laborie Medical Technologies Corp. | $104.20 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Sun Pharmaceutical Industries INC. | $92.44 | 2019-2024 | Yonsa |
| Astrazeneca Pharmaceuticals LP | $83.76 | 2021-2023 | Lynparza |
| Endo USA, INC. | $81.01 | 2024-2025 | Xiaflex |
| Procept Biorobotics Corporation | $69.70 | 2024-2025 | Aquabeam System |
| Travere Therapeutics, INC. | $64.40 | 2019-2021 | |
| Janssen Scientific Affairs, LLC | $62.40 | 2020-2024 | Erleada, Akeega |
| Antares Pharma, INC. | $62.28 | 2019-2025 | Xyosted |
| Foundation Medicine, INC. | $58.48 | 2021-2023 | Foundationone Liquid Cdx |
| Rochester Medical Corporation | $52.68 | 2020-2021 | |
| Progenics Pharmaceuticals, INC. | $51.14 | 2023-2024 | Pylarify |
| Boston Scientific Corporation | $50.20 | 2019-2023 | Lithovue |
| Olympus America INC. | $49.98 | 2020-2024 | Itind System |
| Ferring Pharmaceuticals INC. | $46.43 | 2024 | Adstiladrin |
| Telix Pharmaceuticals | $45.02 | 2024 | Illuccix |
| Palette Life Sciences, INC. | $37.82 | 2019-2023 | |
| Tolmar, INC. | $36.92 | 2023 | |
| Merck Sharp & Dohme LLC | $33.86 | 2023 | Keytruda |
| Cook Medical LLC | $32.48 | 2022-2024 | Cook |
| Edap Technomed INC | $29.99 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $24.76 | 2024 | |
| Celltrion USA INC. | $24.15 | 2025 | Vegzelma |
| Verity Pharmaceuticals INC. | $24.05 | 2025 | Trelstar |
| Organon LLC | $22.35 | 2025 | |
| Abbvie INC. | $21.65 | 2024 | |
| Genzyme Corporation | $20.35 | 2022 | |
| Immunitybio, INC. | $20.19 | 2024 | |
| Alexion Pharmaceuticals, INC. | $19.08 | 2019 | |
| Dentsply Ih Ab | $15.90 | 2023 | Lofric |
| Cycle Pharmaceuticals INC | $15.74 | 2025 | Venxxiva |
| Tolmar Pharmaceuticals, INC. | $13.38 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Weatherly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.